Graf Akcie BIOL (Biolase Inc). Diskuze k akciím BIOL. Aktuální informace BIOL.

Základní informace o společnosti Biolase Inc (Akcie BIOL)

Skvělé pro velmi rychlou analýzu společnosti. Investor může porovnat různé ukazatele s konkurenčními firmami.

Tržní kapitalizace 94.53M
Hodnota podniku (EV) 77.46M
Tržby 32.309M
EBITDA -18.29
Zisk -13.73
Růst v tržbách Q/Q 210.89 %
Růst v tržbách Y/Y 21.70 %
P/E (Cena vůči ziskům) N/A
Forward P/E -0.04
EV/Sales 2.40
EV/EBITDA N/A
EV/EBIT N/A
PEG N/A
Price/Sales 2.88
P/FCF N/A
Price/Book 9.27
Účetní hodnota na akcii 0.06
Hotovost na akcii 0.11
FCF vůči ceně -14.84 %
Počet zaměstnanců 135
Tržba na zaměstnance 239.326k
Profit margin -73.88 %
Operating margin -57.42 %
Gross margin 27.10 %
EBIT margin -35.15 %
EBITDA margin -56.61 %
EPS - Zisk na akcii N/A
EPS - Kvartální růst -83.33 %
EPS - Očekávaný růst příští rok -85.71 %
Return on assets -26.44 %
Return on equity -60.60 %
ROIC -41.63 %
ROCE -23.40 %
Dluhy/Equity 3.09
Čistý dluh/EBITDA 2.54
Current ratio 4.35
Quick Ratio 3.35
Volatilita 5.22
Beta 1.37
RSI 36.86
Cílová cena analytiků 1
Známka akcie (dle analytiků) 1.00
Insider ownership 5.39 %
Institutional ownership 18.08 %
Počet akcií 151.194M
Procento shortovaných akcií 3.81 %
Short ratio 3.11 %
Dividenda 0.00
Procentuální dividenda 0.00 %
Dividenda/Zisk N/A %
Obchodovaná od 2004
Země United States

Finanční výsledky akcie BIOL

Finanční výsledky společnosti, napoví investorovi, zda se jedná o kvalitní společnost.

# 2020 2019 2018 2017 2016 2015
Revenue$37.799$46.155$46.926$51.81$48.475$47.656
Cost Of Goods Sold$23.511$29.26$31.8$31.502$32.525$29.484
Gross Profit$14.288$16.895$15.126$20.308$15.95$18.172
Research And Development Expenses$4.765$5.203$6.229$7.799$7.283$4.577
SG&A Expenses$25.144$29.892$26.43$27.471$28.952$31.229
Other Operating Income Or Expenses-$-2.685$-0.505-$0.37$-0.307
Operating Expenses$53.42$67.04$64.964$66.772$68.39$65.597
Operating Income$-15.621$-20.885$-18.038$-14.962$-19.915$-17.941
Total Non-Operating Income/Expense$-2.278$-0.568$0.605$-0.258$-0.185$-0.873
Pre-Tax Income$-17.899$-21.453$-17.433$-15.22$-20.1$-18.814
Income Taxes$-0.044$0.063$-0.582$0.151$0.178$0.112
Income After Taxes$-17.855$-21.516$-16.851$-15.371$-20.278$-18.926
Other Income------
Income From Continuous Operations$-17.855$-21.516$-16.851$-15.371$-20.278$-18.926
Income From Discontinued Operations------
Net Income$-17.855$-21.516$-20.829$-17.555$-20.278$-18.926
EBITDA$-14.311$-19.612$-16.835$-13.914$-19.035$-16.917
EBIT$-15.621$-20.885$-18.038$-14.962$-19.915$-17.941
Basic Shares Outstanding23211512128
Shares Outstanding23211512128
Basic EPS$-0.77$-1.05$-1.41$-1.45$-1.75$-2.25
EPS - Earnings Per Share$-0.77$-1.05$-1.41$-1.45$-1.75$-2.25
# 2020 2019 2018 2017 2016 2015
Current Ratio1.04812.0862.69631.88672.30373.3929
Long-term Debt / Capital-0.4942--0.0063-
Debt/Equity Ratio3.10130.9772--0.0064-
Gross Margin37.799936.604932.233739.197132.903638.1316
Operating Margin-41.3265-45.2497-38.4392-28.8786-41.083-37.6469
EBIT Margin-41.3265-45.2497-38.4392-28.8786-41.083-37.6469
EBITDA Margin-37.8608-42.4916-35.8756-26.8558-39.2677-35.4982
Pre-Tax Profit Margin-47.3531-46.4803-37.15-29.3766-41.4647-39.4788
Net Profit Margin-47.2367-46.6168-44.3869-33.8834-41.8319-39.7138
Asset Turnover1.18691.19831.09171.23531.14730.8022
Inventory Turnover Ratio2.13832.3892.58582.32952.58832.3572
Receiveable Turnover4.3154.15364.63515.29545.41745.2928
Days Sales In Receivables84.589587.875278.746568.92867.375368.9621
ROE - Return On Equity-4736.037-194.0303-57.5905-69.6624-81.3561-45.0019
Return On Tangible Equity-1260.946-263.5796-63.9895-80.3124-92.3911-48.5083
ROA - Return On Assets-56.0649-55.8625-39.203-36.6491-47.9941-31.8603
ROI - Return On Investment-411.216-98.1345-57.5906-69.6624-80.8404-45.0019
Book Value Per Share0.13810.50471.42951.63282.14033.6183
Operating Cash Flow Per Share0.13770.561-0.37480.65380.391-0.4996
Free Cash Flow Per Share0.15420.5862-0.30880.690.2615-0.4199